Literature DB >> 19914256

Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function?

Ruth H Willott1, Aldrin V Gomes, Audrey N Chang, Michelle S Parvatiyar, Jose Renato Pinto, James D Potter.   

Abstract

Troponin (Tn) is a critical regulator of muscle contraction in cardiac muscle. Mutations in Tn subunits are associated with hypertrophic, dilated and restrictive cardiomyopathies. Improved diagnosis of cardiomyopathies as well as intensive investigation of new mouse cardiomyopathy models has significantly enhanced this field of research. Recent investigations have showed that the physiological effects of Tn mutations associated with hypertrophic, dilated and restrictive cardiomyopathies are different. Impaired relaxation is a universal finding of most transgenic models of HCM, predicted directly from the significant changes in Ca(2+) sensitivity of force production. Mutations associated with HCM and RCM show increased Ca(2+) sensitivity of force production while mutations associated with DCM demonstrate decreased Ca(2+) sensitivity of force production. This review spotlights recent advances in our understanding on the role of Tn mutations on ATPase activity, maximal force development and heart function as well as the correlation between the locations of these Tn mutations within the thin filament and myofilament function. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914256     DOI: 10.1016/j.yjmcc.2009.10.031

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  114 in total

1.  Effect of ovariectomy on intracellular Ca2+ regulation in guinea pig cardiomyocytes.

Authors:  Hsiang-Yu Yang; Jahn M Firth; Alice J Francis; Anita Alvarez-Laviada; Kenneth T MacLeod
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-04       Impact factor: 4.733

2.  Hypertrophic cardiomyopathy-linked mutation D145E drastically alters calcium binding by the C-domain of cardiac troponin C.

Authors:  Nicholas Swindle; Svetlana B Tikunova
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

3.  Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice.

Authors:  Cintia B Ueta; Behzad N Oskouei; Emerson L Olivares; Jose R Pinto; Mayrin M Correa; Gordana Simovic; Warner S Simonides; Joshua M Hare; Antonio C Bianco
Journal:  Mol Endocrinol       Date:  2012-03-08

4.  Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

Authors:  Jose Renato Pinto; Jill D Siegfried; Michelle S Parvatiyar; Duanxiang Li; Nadine Norton; Michelle A Jones; Jingsheng Liang; James D Potter; Ray E Hershberger
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

5.  Differential responses of induced pluripotent stem cell-derived cardiomyocytes to anisotropic strain depends on disease status.

Authors:  Young Wook Chun; David E Voyles; Rutwik Rath; Lucas H Hofmeister; Timothy C Boire; Henry Wilcox; Jae Han Lee; Leon M Bellan; Charles C Hong; Hak-Joon Sung
Journal:  J Biomech       Date:  2015-10-08       Impact factor: 2.712

6.  Biological actions of green tea catechins on cardiac troponin C.

Authors:  Naoto Tadano; Cheng-Kun Du; Fumiaki Yumoto; Sachio Morimoto; Mika Ohta; Ming-Fang Xie; Koji Nagata; Dong-Yun Zhan; Qun-Wei Lu; Yoshikazu Miwa; Fumi Takahashi-Yanaga; Masaru Tanokura; Iwao Ohtsuki; Toshiyuki Sasaguri
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 7.  Nuclear tropomyosin and troponin in striated muscle: new roles in a new locale?

Authors:  P Bryant Chase; Mark P Szczypinski; Elliott P Soto
Journal:  J Muscle Res Cell Motil       Date:  2013-08-02       Impact factor: 2.698

8.  Molecular determinants of cardiac myocyte performance as conferred by isoform-specific TnI residues.

Authors:  Brian R Thompson; Evelyne M Houang; Yuk Y Sham; Joseph M Metzger
Journal:  Biophys J       Date:  2014-05-20       Impact factor: 4.033

9.  Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.

Authors:  Marco L Alves; Fernando A L Dias; Robert D Gaffin; Jillian N Simon; Eric M Montminy; Brandon J Biesiadecki; Aaron C Hinken; Chad M Warren; Megan S Utter; Robert T Davis; Sadayappan Sakthivel; Jeffrey Robbins; David F Wieczorek; R John Solaro; Beata M Wolska
Journal:  Circ Cardiovasc Genet       Date:  2014-02-28

10.  Sarcomere neutralization in inherited cardiomyopathy: small-molecule proof-of-concept to correct hyper-Ca2+-sensitive myofilaments.

Authors:  Brian R Thompson; Joshua Martindale; Joseph M Metzger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.